Goldman Sachs’s Forte Biosciences FBRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | – | Sell |
-20,776
| Closed | -$11.2K | – | 4888 |
|
2024
Q2 | $11.2K | Buy |
20,776
+2
| +0% | +$1 | ﹤0.01% | 4635 |
|
2024
Q1 | $14.5K | Buy |
20,774
+34
| +0.2% | +$24 | ﹤0.01% | 4630 |
|
2023
Q4 | $17K | Sell |
20,740
-13,016
| -39% | -$10.7K | ﹤0.01% | 4618 |
|
2023
Q3 | $22.3K | Buy |
33,756
+12,937
| +62% | +$8.56K | ﹤0.01% | 4552 |
|
2023
Q2 | $21.7K | Buy |
20,819
+197
| +1% | +$205 | ﹤0.01% | 4747 |
|
2023
Q1 | $20.8K | Buy |
20,622
+289
| +1% | +$292 | ﹤0.01% | 4878 |
|
2022
Q4 | $20.3K | Sell |
20,333
-50
| -0.2% | -$50 | ﹤0.01% | 4891 |
|
2022
Q3 | $22K | Sell |
20,383
-12,419
| -38% | -$13.4K | ﹤0.01% | 5149 |
|
2022
Q2 | $43K | Buy |
32,802
+5,182
| +19% | +$6.79K | ﹤0.01% | 5309 |
|
2022
Q1 | $40K | Sell |
27,620
-57,620
| -68% | -$83.4K | ﹤0.01% | 5504 |
|
2021
Q4 | $182K | Buy |
85,240
+72,206
| +554% | +$154K | ﹤0.01% | 5033 |
|
2021
Q3 | $39K | Sell |
13,034
-24,869
| -66% | -$74.4K | ﹤0.01% | 5235 |
|
2021
Q2 | $1.27M | Buy |
37,903
+4,835
| +15% | +$163K | ﹤0.01% | 3853 |
|
2021
Q1 | $1.13M | Buy |
+33,068
| New | +$1.13M | ﹤0.01% | 3814 |
|
2020
Q1 | – | Sell |
-48,947
| Closed | -$26K | – | 4445 |
|
2019
Q4 | $26K | Buy |
48,947
+25,880
| +112% | +$13.7K | ﹤0.01% | 4245 |
|
2019
Q3 | $15K | Buy |
23,067
+11,970
| +108% | +$7.78K | ﹤0.01% | 4197 |
|
2019
Q2 | $74K | Sell |
11,097
-47,432
| -81% | -$316K | ﹤0.01% | 4047 |
|
2019
Q1 | $636K | Buy |
58,529
+11,442
| +24% | +$124K | ﹤0.01% | 3460 |
|
2018
Q4 | $387K | Buy |
47,087
+24,250
| +106% | +$199K | ﹤0.01% | 3508 |
|
2018
Q3 | $356K | Sell |
22,837
-2,266
| -9% | -$35.3K | ﹤0.01% | 3591 |
|
2018
Q2 | $235K | Buy |
25,103
+11,867
| +90% | +$111K | ﹤0.01% | 3826 |
|
2018
Q1 | $157K | Buy |
13,236
+1,285
| +11% | +$15.2K | ﹤0.01% | 3930 |
|
2017
Q4 | $122K | Buy |
+11,951
| New | +$122K | ﹤0.01% | 3939 |
|
2017
Q3 | – | Sell |
-30,405
| Closed | -$366K | – | 4309 |
|
2017
Q2 | $366K | Buy |
+30,405
| New | +$366K | ﹤0.01% | 3695 |
|